GUERBET (GBT.PA) Stock Fundamental Analysis
Europe - Euronext Paris - EPA:GBT - FR0000032526 - Common Stock
14.82 EUR
-0.16 (-1.07%)
GBT gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 65 industry peers in the Health Care Equipment & Supplies industry. GBT scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. GBT has a valuation in line with the averages, but on the other hand it scores bad on growth.
1. Profitability
1.1 Basic Checks
In the past year GBT was profitable.
In the past year GBT had a positive cash flow from operations.
GBT had positive earnings in 4 of the past 5 years.
In the past 5 years GBT always reported a positive cash flow from operatings.
1.2 Ratios
The Return On Assets of GBT (0.76%) is worse than 61.54% of its industry peers.
The Return On Equity of GBT (2.06%) is worse than 61.54% of its industry peers.
With a Return On Invested Capital value of 3.17%, GBT is not doing good in the industry: 63.08% of the companies in the same industry are doing better.
Measured over the past 3 years, the Average Return On Invested Capital for GBT is significantly below the industry average of 10.04%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROIC | 3.17% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
1.3 Margins
GBT has a Profit Margin of 0.96%. This is in the lower half of the industry: GBT underperforms 61.54% of its industry peers.
GBT's Profit Margin has declined in the last couple of years.
GBT has a worse Operating Margin (4.23%) than 63.08% of its industry peers.
In the last couple of years the Operating Margin of GBT has declined.
With an excellent Gross Margin value of 78.03%, GBT belongs to the best of the industry, outperforming 90.77% of the companies in the same industry.
GBT's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 4.23% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% |
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so GBT is destroying value.
Compared to 1 year ago, GBT has about the same amount of shares outstanding.
Compared to 5 years ago, GBT has more shares outstanding
The debt/assets ratio for GBT is higher compared to a year ago.
2.2 Solvency
An Altman-Z score of 2.07 indicates that GBT is not a great score, but indicates only limited risk for bankruptcy at the moment.
GBT has a Altman-Z score (2.07) which is in line with its industry peers.
GBT has a debt to FCF ratio of 8.88. This is a slightly negative value and a sign of low solvency as GBT would need 8.88 years to pay back of all of its debts.
The Debt to FCF ratio of GBT (8.88) is comparable to the rest of the industry.
GBT has a Debt/Equity ratio of 0.93. This is a neutral value indicating GBT is somewhat dependend on debt financing.
The Debt to Equity ratio of GBT (0.93) is worse than 78.46% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.88 | ||
| Altman-Z | 2.07 |
ROIC/WACC0.47
WACC6.72%
2.3 Liquidity
GBT has a Current Ratio of 2.32. This indicates that GBT is financially healthy and has no problem in meeting its short term obligations.
GBT has a better Current ratio (2.32) than 67.69% of its industry peers.
GBT has a Quick Ratio of 1.03. This is a normal value and indicates that GBT is financially healthy and should not expect problems in meeting its short term obligations.
GBT's Quick ratio of 1.03 is in line compared to the rest of the industry. GBT outperforms 46.15% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 |
3. Growth
3.1 Past
GBT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -76.89%.
GBT shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -15.50% yearly.
Looking at the last year, GBT shows a decrease in Revenue. The Revenue has decreased by -2.01% in the last year.
Measured over the past years, GBT shows a small growth in Revenue. The Revenue has been growing by 0.59% on average per year.
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
3.2 Future
GBT is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by -5.56% yearly.
The Revenue is expected to grow by 3.86% on average over the next years.
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
The Price/Earnings ratio is 24.30, which indicates a rather expensive current valuation of GBT.
72.31% of the companies in the same industry are more expensive than GBT, based on the Price/Earnings ratio.
Compared to an average S&P500 Price/Earnings ratio of 26.87, GBT is valued at the same level.
GBT is valuated reasonably with a Price/Forward Earnings ratio of 10.14.
GBT's Price/Forward Earnings ratio is rather cheap when compared to the industry. GBT is cheaper than 90.77% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 23.46, GBT is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.3 | ||
| Fwd PE | 10.14 |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, GBT is valued cheaper than 93.85% of the companies in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of GBT indicates a rather cheap valuation: GBT is cheaper than 100.00% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 4.17 | ||
| EV/EBITDA | 4.01 |
4.3 Compensation for Growth
GBT's earnings are expected to decrease with -10.60% in the coming years. This may justify a cheaper valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
5. Dividend
5.1 Amount
GBT has a Yearly Dividend Yield of 2.69%.
Compared to an average industry Dividend Yield of 0.98, GBT pays a better dividend. On top of this GBT pays more dividend than 90.77% of the companies listed in the same industry.
Compared to an average S&P500 Dividend Yield of 1.94, GBT pays a bit more dividend than the S&P500 average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
5.2 History
The dividend of GBT decreases each year by -10.05%.
Dividend Growth(5Y)-10.05%
Div Incr Years0
Div Non Decr Years1
5.3 Sustainability
GBT pays out 81.48% of its income as dividend. This is not a sustainable payout ratio.
GBT's earnings and Dividend Rate are declining. This means the current dividend is most likely not sustainable.
DP81.48%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPA:GBT (1/6/2026, 5:20:19 PM)
14.82
-0.16 (-1.07%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners10.22%
Inst Owner ChangeN/A
Ins Owners5.01%
Ins Owner ChangeN/A
Market Cap187.32M
Revenue(TTM)809.67M
Net Income(TTM)7.74M
Analysts46
Price Target15.56 (4.99%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 2.69% |
Yearly Dividend0.5
Dividend Growth(5Y)-10.05%
DP81.48%
Div Incr Years0
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-6.15%
PT rev (3m)-16.44%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.9%
Revenue NY rev (3m)-1.07%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 24.3 | ||
| Fwd PE | 10.14 | ||
| P/S | 0.23 | ||
| P/FCF | 4.17 | ||
| P/OCF | 2 | ||
| P/B | 0.5 | ||
| P/tB | 0.68 | ||
| EV/EBITDA | 4.01 |
EPS(TTM)0.61
EY4.12%
EPS(NY)1.46
Fwd EY9.86%
FCF(TTM)3.55
FCFY23.96%
OCF(TTM)7.41
OCFY49.97%
SpS64.06
BVpS29.76
TBVpS21.75
PEG (NY)N/A
PEG (5Y)N/A
Graham Number20.21
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 0.76% | ||
| ROE | 2.06% | ||
| ROCE | 4.49% | ||
| ROIC | 3.17% | ||
| ROICexc | 3.67% | ||
| ROICexgc | 4.33% | ||
| OM | 4.23% | ||
| PM (TTM) | 0.96% | ||
| GM | 78.03% | ||
| FCFM | 5.54% |
ROA(3y)-0.17%
ROA(5y)0.94%
ROE(3y)-0.15%
ROE(5y)2.51%
ROIC(3y)4.08%
ROIC(5y)3.99%
ROICexc(3y)4.61%
ROICexc(5y)4.69%
ROICexgc(3y)5.43%
ROICexgc(5y)6.06%
ROCE(3y)5.76%
ROCE(5y)5.64%
ROICexgc growth 3Y-4.82%
ROICexgc growth 5Y-5.63%
ROICexc growth 3Y2.13%
ROICexc growth 5Y-2.41%
OM growth 3Y2.51%
OM growth 5Y-2.16%
PM growth 3Y-24.58%
PM growth 5Y-15.99%
GM growth 3Y1.72%
GM growth 5Y0.58%
F-Score5
Asset Turnover0.8
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.93 | ||
| Debt/FCF | 8.88 | ||
| Debt/EBITDA | 3.26 | ||
| Cap/Depr | 66.32% | ||
| Cap/Sales | 6.02% | ||
| Interest Coverage | 1.61 | ||
| Cash Conversion | 86.9% | ||
| Profit Quality | 580.05% | ||
| Current Ratio | 2.32 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 2.07 |
F-Score5
WACC6.72%
ROIC/WACC0.47
Cap/Depr(3y)72.12%
Cap/Depr(5y)80.72%
Cap/Sales(3y)6.9%
Cap/Sales(5y)7.15%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-76.89%
EPS 3Y-21.06%
EPS 5Y-15.5%
EPS Q2Q%-75.86%
EPS Next Y-70.82%
EPS Next 2Y-24.64%
EPS Next 3Y-10.6%
EPS Next 5Y-5.56%
Revenue 1Y (TTM)-2.01%
Revenue growth 3Y4.74%
Revenue growth 5Y0.59%
Sales Q2Q%-7.5%
Revenue Next Year-4.68%
Revenue Next 2Y-1.34%
Revenue Next 3Y0.3%
Revenue Next 5Y3.86%
EBIT growth 1Y-41.57%
EBIT growth 3Y7.37%
EBIT growth 5Y-1.59%
EBIT Next Year50.63%
EBIT Next 3Y21.02%
EBIT Next 5Y21.78%
FCF growth 1Y183.49%
FCF growth 3Y-28.77%
FCF growth 5Y-19.52%
OCF growth 1Y2774.75%
OCF growth 3Y-11.2%
OCF growth 5Y-9.16%
GUERBET / GBT.PA FAQ
What is the fundamental rating for GBT stock?
ChartMill assigns a fundamental rating of 4 / 10 to GBT.PA.
What is the valuation status of GUERBET (GBT.PA) stock?
ChartMill assigns a valuation rating of 5 / 10 to GUERBET (GBT.PA). This can be considered as Fairly Valued.
How profitable is GUERBET (GBT.PA) stock?
GUERBET (GBT.PA) has a profitability rating of 3 / 10.
What is the financial health of GUERBET (GBT.PA) stock?
The financial health rating of GUERBET (GBT.PA) is 4 / 10.
Is the dividend of GUERBET sustainable?
The dividend rating of GUERBET (GBT.PA) is 4 / 10 and the dividend payout ratio is 81.48%.